z-logo
open-access-imgOpen Access
Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
Author(s) -
Senyan Zhang,
Pan-Pan Zhou,
Pengfei Wang,
Yangyang Li,
Liwei Jiang,
Wenxu Jia,
Han Wang,
Angela Fan,
Dongli Wang,
Xuanling Shi,
Xianyang Fang,
Michal Hammel,
Shuying Wang,
Xinquan Wang,
Linqi Zhang
Publication year - 2018
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2018.06.041
Subject(s) - epitope , middle east respiratory syndrome coronavirus , neutralization , glycoprotein , mutagenesis , binding site , viral entry , plasma protein binding , antibody , microbiology and biotechnology , chemistry , receptor , biology , virology , computational biology , mutation , virus , genetics , covid-19 , viral replication , medicine , disease , pathology , gene , infectious disease (medical specialty)
The major mechanism of antibody-mediated neutralization of the Middle East respiratory syndrome coronavirus (MERS-CoV) involves competition with the cellular receptor dipeptidyl peptidase 4 (DPP4) for binding to the receptor-binding domain (RBD) of the spike (S) glycoprotein. Here, we report a unique epitope and unusual neutralizing mechanism of the isolated human antibody MERS-4. Structurally, MERS-4 approached the RBD from the outside of the RBD-DPP4 binding interface. Such binding resulted in the folding of the β5-β6 loop toward a shallow groove on the RBD interface critical for accommodating DPP4. The key residues for binding are identified through site-directed mutagenesis. Structural modeling revealed that MERS-4 binds to RBD only in the "up" position in the S trimer. Furthermore, MERS-4 demonstrated synergy with several reported antibodies. These results indicate that MERS-4 neutralizes MERS-CoV by indirect rather than direct competition with DPP4. This mechanism provides a valuable addition for the combined use of antibodies against MERS-CoV infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom